Work

Anaphylactic reaction to the first dose of subcutaneous methotrexate in JIA: a case report and literature review

Year: 2014

Type: article

Abstract: Methotrexate is the most used DMARD drug in the treatment of juvenile idiopathic arthritis and its efficacy has been demonstrated for more than 20 years. The usual dose is 10 to 15mg/m 2 /week. It is a safe and well-tolerated drug by children and the most common side effects are gastrointestinal, hematologic and liver toxicity.

Source: Pediatric Rheumatology

DOI: 10.1186/1546-0096-12-s1-p200